Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mutat Res Rev Mutat Res ; 776: 23-31, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29807575

RESUMO

Studies on monogenic diseases are considered valuable because they give insights and expand our knowledge on gene function and regulation. Despite all the current advancement in science and technology, a deep understanding and knowledge as to why only those particular genes are affected in a disease is still vague. We also lack profound illumination as to why only certain mutations are seen in a disease. Though useful from a research perspective, a majority of these diseases are lethal resulting in death of the affected individual. Unfortunately, in the fast - growing land of India, the incidence of monogenic diseases is very high with few counter-measures in place. This article encompasses a list of all monogenic diseases ever to be reported in India with special focus on five diseases which has been stated to have the highest incidence in India. Here, we discuss about the limited research carried out in India on these high incidence monogenic diseases, the other diseases related to those genes, the range of treatments available for these diseases in India in contrast to its availability around the world and the need to develop treatment strategies to reduce the mortality and morbidity due to these rare but daunting diseases.


Assuntos
Doenças Genéticas Inatas/epidemiologia , Mutação , Anemia Falciforme/epidemiologia , Anemia Falciforme/genética , Anemia Falciforme/terapia , Doenças Genéticas Inatas/genética , Doenças Genéticas Inatas/terapia , Humanos , Doença de Huntington/epidemiologia , Doença de Huntington/genética , Doença de Huntington/terapia , Incidência , Índia/epidemiologia , Distrofia Muscular de Duchenne/epidemiologia , Distrofia Muscular de Duchenne/genética , Distrofia Muscular de Duchenne/terapia , Neurofibromatose 1/epidemiologia , Neurofibromatose 1/genética , Neurofibromatose 1/terapia , Talassemia beta/epidemiologia , Talassemia beta/genética , Talassemia beta/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...